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The authors evaluated the contributions of nine genetic (G) variants (selected from 275 single nucleotide
polymorphisms in 11 reverse cholesterol transport pathway genes), ﬁve environmental (E) factors (selected from
10), and G 3 G, E 3 E, and G 3 E interactions in explaining population variance of blood lipid concentrations.
Total cholesterol, triglycerides, and high density lipoprotein (HDL) cholesterol were measured, and low density
lipoprotein (LDL) cholesterol and HDL cholesterol/LDL cholesterol ratio were calculated in a population-based
random sample of 1,543 men and women in Geneva, Switzerland, aged 35–74 years in 1999–2001. Explained
variances (R 2) for HDL cholesterol/LDL cholesterol ratio, HDL cholesterol, and LDL cholesterol, respectively,
were 34%, 33%, and 19%, decomposed into main effects of G (6%, 4%, and 5%) and E (25%, 28%, and 11%),
with just 3%, 2%, and 3% due to G 3 G, E 3 E, and G 3 E interactions, respectively. Risk factor clustering was
only moderate: 70% of study subjects had 3 variants, 75% had 2 environmental exposures, and 69% had 5
of both types of factors. Multiple genes with weak associations, together with more dominating environmental
factors, are involved in determining blood lipid concentrations. Interactions added little explained variance.
Increasing trends in hypercholesterolemia are attributable to environmental changes affecting populations as
a whole. Reducing obesity and smoking and moderating alcohol intake in entire populations should remain the
primary strategies for lipid control.
body mass index; environment; genes; genetics; hypercholesterolemia; lipids; metabolism; risk factors
Abbreviations: BMI, body mass index; E, environment or environmental; G, gene or genetic; HDL, high density lipoprotein;
LDL, low density lipoprotein; SNP, single nucleotide polymorphism; T, tertile.
Both genetic (G) and environmental (E) factors control the
concentrations of blood lipids, but the relative importance of
these two broad categories of determinants has not been
assessed systematically. Evidence also exists that synergistic
or antagonistic interactions between determinants play a role
in the etiology of common traits, but their actual contribution
to the population variation of a complex phenotype, such as
blood lipids, remains elusive (1). The presence of interactions
would be of high clinical and public health relevance because
it implies that specific subgroups of the populationmay benefit
more than others from targeted prevention (e.g., physical
activity (2)) or therapeutic (e.g., statins (3)) strategies.
Assessing the relative importance of interactions regard-
ing common disorders is currently hampered by their
formidable number between even a limited set of determi-
nants (4) and by the paucity of biologic knowledge relative
to their mechanisms. The reverse transport of cholesterol
from peripheral tissues to the liver may be an exception in
that it lends itself well to assessment of the relative roles
of G and E main and interaction effects, for two reasons.
There exists a rich biochemical and physiologic literature
on the architecture of this pathway (5–8), and its environ-
mental determinants have also been studied extensively
(2, 9–22).
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Figure 1 depicts the overall study design strategy used to
determine the relative contributions of G and E main and
interaction effects to the population variance of blood lipid
concentrations. A subset of subjects with extreme pheno-
types was selected from the total random sample of 1,543
untreated subjects because their respective high density
lipoprotein (HDL) cholesterol and low density lipoprotein
(LDL) cholesterol concentrations were in the lowest (or
highest) tertile (T1, 33.3rd percentile) and highest (or
lowest) tertile (T3, 66.7th percentile), separately by gender.
The tertile boundaries (mmol/liter) for HDL cholesterol and
LDL cholesterol were, for men/women, as follows: HDL
cholesterol—T1 5 1.06/1.33, T3 5 1.32/1.63; LDL
cholesterol—T1 5 3.54/3.22, T3 5 4.30/4.04 (to convert to
mg/dl, multiply by 38.6). For 186 subjects, HDL cholesterol
was <T1 and LDL cholesterol was >T3 (low HDL, high
LDL), considered an atherogenic phenotype (‘‘cases’’). At the
other extreme were 185 subjects whose HDL cholesterol was
>T3 and LDL cholesterol was <T1 (high HDL, low
LDL), considered a nonatherogenic phenotype (‘‘controls’’).
The case-control study subjects also tended to score in the
corresponding extreme tertiles of triglycerides because
HDL cholesterol, LDL cholesterol, and triglyceride levels
are highly correlated in the extreme tails of their distribu-
tions. The entire coding DNA and the immediately adjacent
noncoding DNA, including both 5# and 3# untranslated
regions and a portion of each intron, were assayed first in
a purposefully selected resequencing subsample of 95 of the
case-control study subjects in whom the largest genetic
variability was anticipated. Forty-eight subjects had a non-
atherogenic lipid profile and were sedentary; hence, they
were expected to have a ‘‘protective’’ genetic constitution.
The 47 other subjects had an atherogenic lipid profile but
were physically active; hence, they were expected to have
a ‘‘deleterious’’ genetic constitution.
Eleven genes and 10 environmental determinants of blood
lipids involved in the reverse transport of cholesterol pathway
were analyzed. The 11 geneswere adenosine 5#-triphosphate–
binding cassette protein 1 (ABCA1), apolipoprotein A1
(APOA1), apolipoprotein E (APOE), cholesteryl-ester transfer
protein (CETP), endothelial lipase (EL), hepatic lipase (HL),
lecithin–cholesterol acetyl transferase (LCAT), lipoprotein
lipase (LPL), low density lipoprotein receptor (LDLR),
phospholipid transfer protein (PLTP), and scavenger receptor
class B type I (SR-BI). The 10 environmental factors were
gender, age, educational level, country of birth, dietary fiber,
dietary fat, physical activity, bodymass index (BMI), cigarette
smoking, and alcohol intake. Even though these factors also
have genetic determinants, they are referred to as ‘‘environ-
mental’’ because, as opposed to polymorphisms, their assess-
ment is not DNA based.
A previous work established that a subset of nine genetic
variants (mostly single nucleotide polymorphisms (SNPs),
out of a total of 275), spanning seven candidate genes,
together with five of the 10 environmental factors (BMI,
alcohol intake, current cigarette smoking, gender, and age)
explained the largest amount (65 percent) of the lipid
variance for the subjects with extreme phenotypes (23).
The present study extends this previous work by 1)
implementing the model developed for the phenotypically
extreme subjects to the whole population-based sample and
2) estimating the absolute and relative contributions of the
FIGURE 1. Sampling design and analytical strategy used to assess the relative contributions of genetic (G) variants, environmental (E) factors,
and G3 G, E3 E, and G3 E interactions to the variance in blood lipid concentrations in the Geneva, Switzerland, general adult study population.
The population-based random sample of residents was obtained from January 1999 through February 2001. Refer to the introductory paragraphs
of the text for further details.
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genetic, environmental, and interaction effects on blood
lipid levels in a general European adult population.
MATERIALS AND METHODS
Subject selection
Geneva (city and canton, Switzerland) has a population of
about 400,000 distributed over an area of 242 km2. Potential
survey subjects were randomly selected uniformly over the
26-month period from January 1999 through February 2001
to represent the 200,000 men and women noninstitutional-
ized residents aged 35–74 years, and they were asked to
participate in a general population health survey. About
0.5 percent of the target population was sampled each year
from the official residents’ register. The study was approved
by the relevant institutional ethics committees in Geneva
and New York, and all participants provided informed
written consent.
The intensive and standardized recruitment of a potential
subject lasted from 2 weeks to 2 months. Eligible subjects
were identified by using a standardized procedure from an
annual list of residents established by the local government.
All legal residents of the canton are registered. The only
information from the list used in the survey (i.e., gender,
age, and whether the person is of Swiss origin) is highly
accurate. Stratified random sampling, based on the list by
gender within 10-year age strata, was proportional to the
corresponding population distributions. Selected subjects
were mailed an invitation to participate; if they did not
respond, as many as seven telephone attempts at different
times on various days of the week were made. If telephone
contact was unsuccessful, two more letters were mailed.
Subjects not reached (15 percent of men and 19 percent of
women) were replaced by using the same selection protocol.
Routine survey quality monitoring had shown that these
subjects no longer resided in the canton, so they were not
eligible for the study. Subjects who refused to participate
were not replaced, and participating subjects were not
eligible for future surveys. The participation rate was
61 percent. The population-based sample used in the anal-
yses comprised 1,543 subjects not under treatment for
hypercholesterolemia.
Survey measurements
Each participant filled out several self-administered,
standardized questionnaires covering risk factors for the
major lifestyle chronic diseases, sociodemographic charac-
teristics, educational and occupational histories, and re-
productive history (women only). A semiquantitative food
frequency questionnaire, previously developed and tested in
the Geneva general adult population (24), asked about
serving sizes and consumption frequencies of 80 food items
organized by food groups during the 4 previous weeks,
which were converted into daily energy, nutrient, and
alcohol intakes in the analyses. A physical activity fre-
quency questionnaire, also developed previously in the same
target population and validated by using a heart rate monitor
(25), measured total and activity-specific energy expendi-
tures based on which of 70 physical activities grouped by
general type (e.g., occupational, housework, leisure time,
sports) were performed in the past 7 days.
During a scheduled appointment at a mobile epidemiol-
ogy clinic (housed in a special bus), the questionnaires were
checked for completion by trained interviewers, and a phys-
ical examination was performed. After participants removed
their shoes and heavy outerwear, their weight was measured
by using a medical scale (precision, 0.5 kg), and height was
measured with a medical gauge (precision, 1 cm), from
which BMI was calculated.
Laboratory measurements
Total plasma cholesterol, HDL cholesterol, and trigly-
cerides were assayed (mmol/liter) in fasting blood (Bayer
Technicon Diagnostics, Brussels, Belgium, with monthly
quality control checks performed by the Swiss Center for
Quality Control in Clinical Chemistry and Hematology
(Geneva)). Total genomic DNA was extracted from ethyl-
enediaminetetraacetic acid (EDTA) blood (Gentra Puregene
blood kit; BioConcept, Allschwil, Switzerland). LDL cho-
lesterol (mmol/liter) was calculated as (cholesterol – HDL
cholesterol – triglycerides/2.2) (26).
SNPs were assayed by using modified template-directed
dye-terminator incorporation with fluorescence polarization
(TDI-FP) detection (Acycloprime-FP SNP Detection Kit;
PerkinElmer Life and Analytical Sciences, Inc., Shelton,
Connecticut). Information on primers to amplify and detect
SNPs is available from the authors on request.
Statistical analyses
Linear regression models were used to evaluate the joint
contributions (measured by the squared multiple correlation
coefficient, R2) of the nine genetic variants, five environ-
mental factors, and their interaction effects to the variation
in log(HDL cholesterol/LDL cholesterol ratio), HDL cho-
lesterol, and LDL cholesterol (log data reported as geometric
mean). The nine variants (across seven genes) comprised
two ABCA1 SNPs (exons 32b.1 30 and 50b.3038), APOE2
(e2/e2 or e2/e3), two HL SNPs (exon 1b. – 280 promoter
and 3b. – 279), LPL S447X (exon 9.b99), LDLR2 (rs2228671
on exon 2), PLTP exon 1b. 1 26, and SR-BI A350A (exon
8b.41). Each genetic variant was coded 0 if the rare variant
was absent and 1 if present (as heterozygote/homozygote).
This coding assumes that the rare allele effect is dominant.
Because homozygotes for the rare allele were extremely
rare, it is essentially equivalent to an additive model,
consistent with most evidence about the genetics of many
quantitative traits.
The five environmental factors were gender (reference 5
women vs. men), cigarette smoking (reference 5 (never
smoker (<100 lifetime cigarettes) 1 former smoker
(quit 1 year preinterview)) vs. current smoker), alcohol
intake (grams of alcohol/day) (reference 5 none vs. low
intake (men/women:1–40/1–20) vs. (medium 1 high in-
takes) (men/women: 41/21)), age (years), and BMI
(weight (kg)/height (m)2). The first three covariates were
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expressed with four dummy variables, and the last two were
continuous. In some analyses, BMI was recoded as normal
weight (BMI <25) vs. overweight (only) (25 BMI <30)
vs. obese (BMI 30), and age was recoded as 1) <55
vs. 55 years or 2) <50 vs. 50 years.
A systematic analytical strategy based on stepdown selec-
tions of G 3 G, E 3 E, and G 3 E interaction effects first
within and then between each of the three types of interactions
for each lipid outcome was used to obtain the final models.
Details of these procedures are described in the Appendix.
All final p values, regression coefficients, and cumula-
tive and total R2’s were obtained by using Monte Carlo
bootstrap procedures (resampling with replacement) (27). A
final p  0.05 (p 5 0.10) value was considered statistically
(or borderline) significant. Sampling variations in the R2
estimates were also assessed with 95 percent bias-corrected
and accelerated percentile confidence intervals (28). All
bootstrapped estimates were based on 2,000 replicates each,
twice the minimum number recommended for bootstrap
confidence intervals (28).
The final models were further augmented with the other
five environmental factors that had been removed in themodel-
ing process performed for only the extreme-phenotype
subjects (23) and were bootstrapped as above. These other
five environmental factors were 1) educational level (refer-
ence group 5 primary (<9 years of schooling), secondary,
university (13 years of schooling and a Swiss baccalau-
reate degree)); 2) country of birth (reference5 (Switzerland1
all other ( one third France, remainder (mostly northern
Europe) <5 percent each)), Mediterranean (Italy, Spain,
Portugal)); 3) total dietary fat (%); 4) dietary fiber (g/day);
and 5) daily energy expenditure (reference 5 active (10
percent total energy expended in physical activities re-
quiring four or more times the basal metabolic rate,
sedentary (<10 percent expended in physical activities
requiring four or more times the basal metabolic rate)
(29)). The first two covariates were expressed with three
dummy variables, and the last three were continuous (in the
descriptive analyses, dietary fat and dietary fiber were coded
as below the overall median (percentile (P)50) vs. P50).
These additional analyses were used to assess any residual
contributions of the other environmental factors, which
reasonably might have been expected to play a role in
determining blood lipid concentrations in the general
population despite contraindications when focusing on only
the extreme-phenotype subjects.
RESULTS
HDL cholesterol, LDL cholesterol, and log(HDL
cholesterol/LDL cholesterol ratio) outcome measures
HDL cholesterol and LDL cholesterol were only mod-
estly negatively correlated in the total sample (r 5 20.15)
and by gender (men: r 5 20.07; women: r 5 20.15). As
expected, both HDL cholesterol and LDL cholesterol,
respectively, were strongly correlated with log(HDL cho-
lesterol/LDL cholesterol ratio) (total: r5 0.77,20.73; men:
r 5 0.74, 20.70; women: r 5 0.73, 20.77).
Associations between environmental factors and
blood lipids
Table 1 describes in detail all 10 environmental character-
istics of the population-based sample and their effects on
blood lipid measurements. For the five environmental
factors retained in the modeling process in the Morabia
et al. (23) study, age and gender differences in lipid levels
were in the expected directions; overweight or obesity and
cigarette smoking were individually associated with higher
serum total cholesterol, LDL cholesterol, and triglycerides
but with a lower HDL cholesterol and HDL cholesterol/LDL
cholesterol ratio, whereas alcohol intake was associated
with higher serum total cholesterol, HDL cholesterol, and
HDL cholesterol/LDL cholesterol ratio.
For the five environmental factors removed by the
modeling process in the Morabia et al. (23) study, seden-
tarity was associated with lower HDL cholesterol and HDL
cholesterol/LDL cholesterol ratio but higher triglycerides;
more dietary fiber was associated with lower triglycerides;
Mediterranean birth was associated with lower HDL
cholesterol and HDL cholesterol/LDL cholesterol ratio;
university education was associated with higher HDL
cholesterol but lower triglycerides; and dietary fat was not
associated with any of the lipid outcomes.
Clustering of genetic and environmental determinants
of blood lipids
The symmetrical distributions of the numbers of SNPs, of
(relevant) environmental exposures (counting one each for
age 55 years, BMI 25 kg/m2 (overweight), current
smoking, or any alcohol intake, but excluding gender),
and of both types of factors harbored by the study subjects
are shown in Web Appendix figure A1. (This figure and four
supplementary Appendix tables (each referred to as ‘‘Web
Appendix table’’ in the text) are posted on the Journal’s
website (http://aje.oupjournals.org/).) There was practically
no correlation (r 5 20.004) between the numbers of SNPs
and the numbers of environmental factors. The median
numbers were three out of a maximum of nine SNPs, two
out of four environmental exposures (apart from gender),
and five out of 13 genetic and environmental factors
combined. About 70 percent of the study subjects had three
SNPs or fewer, 75 percent had two or fewer environmental
exposures, and 69 percent had five or fewer of both types of
factors.
Cumulative genetic, environmental, and interaction
effects on blood lipids
Consistent with the model developed for the phenotypi-
cally extreme subjects, the nine SNPs and five environmental
factors had significant effects (bootstrapped p < 0.05 either
individually or through interaction) on all ormost of the three
lipid outcomes (table 2). For HDL cholesterol/LDL choles-
terol ratio, all but one (SR-BI A350A) of the nine SNPs and all
five environmental factors had significant effects. For HDL
cholesterol alone, all nine SNPs and all five environmental
factors had significant effects. For LDL cholesterol alone, six
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of the nine SNPs and four environmental factors (excluding
alcohol intake) had significant effects. Of the nine genetic
variants, four (APOE2, the PLTP SNP, and the two ABCA1
SNPs) had significant effects on all three lipid outcomes;
a fifth, SR-BI A350A, had significant effects on HDL
cholesterol and LDL cholesterol and a borderline effect on
HDL cholesterol/LDL cholesterol ratio. Another three
variants (LPL S447X and the two HL SNPs) had significant
effects on the HDL cholesterol/LDL cholesterol ratio and on
HDL cholesterol. The ninth LDLR SNP had significant
effects on HDL cholesterol and LDL cholesterol.
On the whole, because the SNPs had been sampled from
ametabolic pathwayprimarily forHDLcholesterol, themodel
predicted LDL cholesterol less well. Remarkably, of the 19
additional interactions (excluding hierarchically required
terms) across all three lipid outcomes, all but two were
confirmed in the final bootstrapped models. The two non-
confirmed interactions were of borderline statistical signifi-
cance (SR-BI3 alcohol medium1 high intakes3 gender for
HDL cholesterol/LDL cholesterol ratio (p5 0.098) and SR-BI
A350A3 age for HDL cholesterol (p5 0.061)).
The total R2 was 33.7 percent for the HDL cholesterol/
LDL cholesterol ratio, 33.0 percent for HDL cholesterol,
and 18.5 percent for LDL cholesterol. These three total
R2’s, respectively, were decomposed into the main effects
of the nine genetic variants (6 percent, 4 percent, and
5 percent) and the five environmental factors (25 percent,
28 percent, and 11 percent), with the remainder (3 percent,
TABLE 1. Environmental factors and their effects on blood lipids in the population-based study sample (n 5 1,543), Geneva,
Switzerland, 1999–2001
Environmental factor
and category
No.
Serum total
cholesterol (mmol/liter)*
(mean (SEy))
HDL cholesterol
(mmol/liter)*
(mean (SE))
LDL cholesterol
(mmol/liter)*
(mean (SE))
HDL cholesterol/LDL
cholesterol ratio
(mean (SE)z)
Triglycerides
(mmol/liter)*
(mean (SE)z)
Included in the ﬁnal logistic model (23)
Gender
Men (a) 751 5.79 (0.04) 1.21 (0.01) 3.92 (0.03) 0.31 (0.01) 1.25 (0.02)
Women (b) 792 5.70 (0.03) 1.50 (0.01) 3.71 (0.03) 0.41 (0.01) 0.96 (0.02)
pb 2 a§ 0.073 <0.0001 <0.0001 <0.0001 <0.0001
Age group (years)
35–54 (a) 1,051 5.60 (0.03) 1.35 (0.01) 3.70 (0.03) 0.36 (0.01) 1.19 (0.02)
55–74 (b) 492 6.04 (0.04) 1.38 (0.01) 4.06 (0.04) 0.34 (0.02) 1.06 (0.02)
pb 2 a{ <0.0001 0.067 <0.0001 <0.0001 <0.0001
Body mass index#
Normal (a) 884 5.66 (0.03) 1.43 (0.01) 3.74 (0.03) 0.38 (0.01) 0.96 (0.02)
Overweight (b) 520 5.85 (0.04) 1.27 (0.01) 3.91 (0.04) 0.32 (0.02) 1.27 (0.02)
Obese (c) 139 5.88 (0.08) 1.20 (0.03) 3.94 (0.07) 0.30 (0.03) 1.42 (0.04)
pb 2 a 0.0010 <0.0001 0.0008 <0.0001 <0.0001
pc 2 b 0.74 0.013 0.71 0.037 0.015
pc 2 a 0.015 <0.0001 0.013 <0.0001 <0.0001
Cigarette smoking
Current (a) 399 5.84 (0.05) 1.30 (0.02) 3.90 (0.04) 0.33 (0.02) 1.22 (0.02)
Not current (b) 1,144 5.71 (0.03) 1.37 (0.01) 3.78 (0.03) 0.36 (0.01) 1.06 (0.01)
pb 2 a 0.027 <0.0001 0.025 <0.0001 <0.0001
Alcohol intake#
None (a) 191 5.70 (0.07) 1.24 (0.02) 3.85 (0.06) 0.32 (0.03) 1.15 (0.04)
Low (b) 1,177 5.72 (0.03) 1.36 (0.01) 3.80 (0.03) 0.36 (0.01) 1.08 (0.01)
Medium 1 high (c) 175 5.93 (0.07) 1.45 (0.02) 3.85 (0.07) 0.38 (0.03) 1.17 (0.04)
pb 2 a 0.77 <0.0001 0.49 0.0003 0.13
pc 2 b 0.027 0.0007 0.49 0.032 0.037
pc 2 a 0.0094 <0.0001 0.99 <0.0001 0.65
Removed from the ﬁnal logistic model (23)
Educational level#
University (a) 601 5.69 (0.04) 1.37 (0.01) 3.78 (0.04) 0.36 (0.01) 1.03 (0.02)
Secondary (b) 850 5.80 (0.03) 1.35 (0.01) 3.84 (0.03) 0.35 (0.01) 1.14 (0.02)
Table continues
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2 percent, and 3 percent) being jointly due to the G 3 G,
G 3 E, and E 3 E interaction effects.
Detailed 2 3 2 and 2 3 2 3 2 tables specifically
illustrating the additional two- and three-way interaction
effects on the lipid outcome measurements are available in
Web Appendix tables A1, A2, and A3.
Stability of the ﬁnal model after augmentation by the
other ﬁve environmental factors
When the finalmodelwith the interactions shown in table 2
was augmented with the other five environmental factors that
had been removed during the modeling process in the
Morabia et al. (23) study, the previous regression coefficients
and p values remained essentially unchanged, as shown in
Web Appendix table A4. Although sedentarity was signifi-
cantly associated with the HDL cholesterol/LDL cholesterol
ratio (p5 0.044) andHDL cholesterol alone (p5 0.017), and
(log)fiber intake showed borderline significant associations
with the HDL cholesterol/LDL cholesterol ratio (p5 0.051)
and LDL cholesterol (p 5 0.065), all of the additional
contributions to the explained variances were marginal.
Specifically, total R2 increased by only 0.7 (to 34.4) percent
for the HDL cholesterol/LDL cholesterol ratio, by only 0.8
(to 33.8) percent for HDL cholesterol, and by only 0.7 (to
19.2) percent for LDL cholesterol.
TABLE 1. Continued
Environmental factor
and category
No.
Serum total
cholesterol (mmol/liter)*
(mean (SE))
HDL cholesterol
(mmol/liter)*
(mean (SE))
LDL cholesterol
(mmol/liter)*
(mean (SE))
HDL cholesterol/LDL
cholesterol ratio
(mean (SE)z)
Triglycerides
(mmol/liter)*
(mean (SE)z)
Primary (c) 92 5.60 (0.10) 1.29 (0.03) 3.74 (0.09) 0.34 (0.04) 1.12 (0.05)
pb 2 a 0.046 0.26 0.27 0.099 <0.0001
pc 2 b 0.072 0.061 0.23 0.55 0.72
pc 2 a 0.42 0.018 0.62 0.17 0.12
Country of birth#
Switzerland (a) 895 5.76 (0.03) 1.37 (0.01) 3.82 (0.03) 0.36 (0.01) 1.08 (0.02)
Other (b) 436 5.75 (0.05) 1.36 (0.02) 3.81 (0.04) 0.35 (0.02) 1.12 (0.02)
Mediterranean (c) 210 5.68 (0.07) 1.28 (0.02) 3.80 (0.06) 0.34 (0.02) 1.12 (0.03)
pb 2 a 0.91 0.35 0.93 0.33 0.18
pc 2 b 0.42 0.0065 0.92 0.14 0.99
pc 2 a 0.33 0.0002 0.86 0.017 0.30
Dietary fat
(Py50 5 34.7%)
<P50 (a) 771 5.75 (0.03) 1.36 (0.01) 3.80 (0.03) 0.36 (0.01) 1.11 (0.02)
P50 (b) 772 5.74 (0.03) 1.35 (0.01) 3.82 (0.03) 0.35 (0.01) 1.08 (0.02)
pb 2 a 0.91 0.54 0.72 0.51 0.32
Dietary ﬁber
(P50 5 14.9 g/day)
<P50 (a) 772 5.75 (0.03) 1.36 (0.01) 3.80 (0.03) 0.36 (0.01) 1.12 (0.02)
P50 (b) 771 5.73 (0.03) 1.35 (0.01) 3.82 (0.03) 0.35 (0.01) 1.07 (0.02)
pb 2 a 0.71 0.79 0.60 0.55 0.048
Sedentarity#
Active (a) 581 5.72 (0.04) 1.40 (0.01) 3.78 (0.04) 0.37 (0.01) 1.03 (0.02)
Sedentary (b) 962 5.76 (0.03) 1.33 (0.01) 3.83 (0.03) 0.35 (0.01) 1.14 (0.01)
pb 2 a** 0.40 <0.0001 0.27 0.0003 <0.0001
Gender-/age-group
adjusted mean 5.74 1.36 3.81 0.35 1.09
* To convert from mmol/liter to mg/dl, multiply serum total cholesterol, high density lipoprotein (HDL) cholesterol, and low density lipoprotein
(LDL) cholesterol by 38.6, triglycerides by 88.
y SE, standard error; P, percentile.
z Geometric mean (SE of log data).
§ p values were adjusted for age (continuous).
{ p values were adjusted for gender, body mass index, cigarette smoking, alcohol intake, educational level, country of birth, dietary fat, and
dietary ﬁber.
# Refer to the text for more information.
** p values were adjusted for gender and age (continuous).
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TABLE 2. Contributions of nine G* variants, ﬁve E* factors, and G 3 G, E 3 E, and G 3 E interactions to prediction of log(HDL* cholesterol/LDL* cholesterol ratio), HDL
cholesterol, and LDL cholesterol in the population-based study sample (n 5 1,543), Geneva, Switzerland, 1999–2001
SNPs* and covariates
log(HDL cholesterol/LDL cholesterol ratio) HDL cholesterol (mmol/liter) LDL cholesterol (mmol/liter)
Cumulative
R2y,z
Final model Cumulative
R2y,z
Final model Cumulative
R2y,z
Final model
Coefﬁcientz p valuez Coefﬁcientz p valuez Coefﬁcientz p valuez
Intercept 0.275 0.40 1.62 0 0.521 0.51
Body mass index (kg/m2) 13.8 20.056 1.8 3 1026 11.6 20.024 0 4.4 0.117 0.00014
APOE2* 16.8 0.863 1.4 3 1026 12.4 0.086 0.00078 7.4 20.490 7.2 3 10214
PLTP* 1b. 1 26 (‘‘P1 1 26’’) 16.9 20.039 0.14 12.5 0.184 0.078 7.4 0.227 0.036
Alcohol intake: medium 1 high 17.1 0.125 0.083 13.4 0.203 5.4 3 10211 7.6 20.058 0.51
Alcohol intake: low 17.1 0.093 0.0023 13.5 0.101 4.3 3 1026 7.7 20.051 0.44
Current cigarette smoker 18.6 20.113 2.2 3 1029 15.6 20.120 5.3 3 10210 7.9 0.148 0.0037
ABCA1* 50b.3038 (‘‘ABC50’’) 19.0 0.067 0.0042 15.8 0.042 0.043 8.2 0.734 0.022
LPL* S447X (‘‘S447X’’) 19.4 0.062 0.0017 16.4 0.069 0.0017 8.3 20.006 0.90
Age (years) 20.5 20.019 0.0012 16.9 0.0003 0.82 13.3 0.050 0.00083
Gender (women) 28.8 0.514 1.5 3 1028 29.3 0.339 0 13.9 21.232 1.3 3 1027
ABCA1 32b. 1 30 (‘‘ABC32’’) 29.1 20.102 5.5 3 1025 29.7 20.057 0.0040 14.1 0.176 0.0087
LDLR2* (rs2228671) 29.5 0.021 0.34 29.7 0.098 0.0056 14.6 20.089 0.12
HL* 1b. 2 280 (‘‘HL1-280’’) 29.8 0.022 0.25 30.4 0.039 0.020 14.6 0.020 0.65
HL 3b. 2 279 (‘‘HL3-279’’) 30.0 0.068 0.0075 30.6 0.046 0.024 14.7 20.010 0.13
HL 3b. 2 279 3 gender 30.2 20.071 0.040 30.8 20.051 0.092 14.8 0.093 0.31
SR-BI* A350A (‘‘A350A’’) 30.3 20.153 0.12 30.9 20.132 0.12 15.0 0.051 0.49
SR-BI A350A 3 gender 30.6 20.063 0.090 31.1 20.063 0.056 15.1 0.131 0.17
Additional interactions (required terms)§
(Gender 3 alcohol intake
medium 1 high) 30.6 0.168 0.19
(A350A 3 alcohol intake
medium 1 high) 30.7 0.087 0.31
A350A 3 alcohol intake
medium 1 high 3 gender 30.9 20.236 0.098
ABC32 3 LDLR2 31.5 0.178 0.00054
HL1-280 3 P1 1 6 32.0 0.127 0.0027
Gender 3 age 32.5 20.004 0.025
APOE2 3 age 32.9 20.006 0.045
Age 3 body mass index 33.2 0.001 0.0072
APOE2 3 body mass index 33.5 20.015 0.025
A350A 3 age 33.7 0.003 0.061
HL1-280 3 P1 1 26 31.7 0.123 0.0025
A350A 3 age 31.9 0.004 0.016
LDLR2 3 S447X 32.2 20.107 0.0047
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DISCUSSION
This study used a statistical model developed a priori that
related genetic and nongenetic factors to blood lipid levels
and produced three main findings. First, altogether, the
nine genetic variants, five environmental factors, and their
interactions explained about one third of the total population
variance for the HDL cholesterol/LDL cholesterol ratio and
HDL cholesterol, which is substantial and indicates that
the selection of factors was on target. Second, the environ-
mental factors were the most important determinants of the
HDL cholesterol/LDL cholesterol ratio and HDL choles-
terol. Finally, interactions contributed only a few extra
percentage points beyond the genetic and environmental
main effects.
In addition to either HDL cholesterol or LDL cholesterol
alone, the combined phenotype based on the HDL choles-
terol/LDL cholesterol ratio was used as an outcome
measurement because biochemical, physiologic, and phar-
macologic data all support the notion that the 11 genes
originally targeted by Morabia et al. (23) converge to
moderate both HDL cholesterol and LDL cholesterol levels.
Moreover, although HDL cholesterol and LDL cholesterol
are relatively independent of each other in the general
population, they are highly (negatively) correlated in the
tails of their distributions, where the working model for the
present study was developed.
There is a growing body of evidence that combinations of
multiple genes harboring predisposing alleles can be
identified that, together, contribute significantly to the
population variance of lipid levels (30). Mootha et al. (31)
have shown that combining the expressions from 22,000
genes of previously defined pathways may increase signal
relative to noise and improve statistical power. Yang et al.
(32) used simulations and empirical data to demonstrate that
the information from several genetic and environmental
factors could be combined to improve prediction of
a multifactorial disease. From an evolutionary perspective,
adaptive pressures may select against any single gene
variant (allele) explaining a large fraction of the population
phenotypic variance. Instead, alleles explaining the variance
of a population trait are more likely to be distributed among
several, or numerous, genes within a pathway or larger
network of gene products. In addition, substantial exposure
heterogeneity in the present population also supported the
idea that different combinations of determinants modulated
blood lipid levels. Typically, a person tended to be exposed
to about a median of only five of the 13 total factors (apart
from gender) included in the models. The present work of
estimating and separating out the relative roles of some
pathway-related genetic and environmental factors and their
epistatic effects in determining blood lipid levels demon-
strates the success of the latter approaches when applied in
a general population setting.
The more dominant role of the environmental factors in
determining blood lipid concentrations makes good sense.
Blood cholesterol levels have been fluctuating over the last
decades in almost all populations of the world (33, 34), and
this phenomenon can be explained only by changes in
exposure to factors totally or in part ‘‘environmental,’’ such
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as diet, physical activity, smoking, alcohol intake, or
overweight/obesity. The very modest contributions of
interactions are unexpected, however. One explanation
could be that their effects were underestimated in the
analysis. The particular genetic variants identified in the
final model represent only a small fraction of all variants
that operate in the population as a whole. Interactions may
also involve factors that are outside of the studied model and
that therefore could not have been accounted for in the
analysis. Up to three-way interactions were feasible to
analyze given the sample size, but there may be important
higher-order interactions. Finally, the set of genetic and
nongenetic factors analyzed were all predictors of lipid
levels before interactions were investigated. Therefore,
some determinants, which are related to lipid levels only
when interacting with other factors, may have been missed.
However, there are also reasons why the results probably
do reflect the relative contributions of genes, environment,
and interactions to HDL cholesterol levels. The main
analytical strategy in the population-based random sample
began with nine variants across seven of 11 reverse transport
of cholesterol pathway genes and five of 10 environmental
factors, which are considered the main determinants of
blood lipid levels (23). All polymorphisms in the exons and
flanking regions of the 11 genes were surveyed, and state-of-
the-art methods were used to assess environmental expo-
sures such as diet (including alcohol intake) (24), physical
activity (25), and smoking (35). The final model implicated
BMI, gender, and APOE, which are the strongest individual
determinants of HDL cholesterol. Remarkably, the cumu-
lative effect of the other eight trait-related gene variants
managed to approach that of only APOE alone. Lastly, the
findings are consistent with the literature: even though work
exists suggesting that some genetically defined subgroups of
the population may benefit more than others from specific
interventions or therapies (2, 3), on the whole no strong
signal is emerging from the wealth of available studies that
cholesterol-reducing preventive strategies should target
subgroups of the population defined by specific G 3 G,
G 3 E, or E 3 E interactions.
It is of note that sedentarity and fiber intake were related
to lipid levels in the full population-based sample but not for
the phenotypically extreme subjects alone. To check the
possibility that these associations might have been con-
founded by the strong effect of BMI in the case-control
study of Morabia et al. (23), the final logistic model for
the phenotypically extreme subjects was augmented by
sedentarity and log(fiber intake), but BMI was excluded.
The results continued to indicate that neither sedentarity
(p 5 0.18) nor fiber intake (p 5 0.60) was associated with
case-control status in the absence of BMI. The absence of
effects of lipid intake, country of birth, and educational level
in the full sample can probably be explained by the extreme
homogeneity of this entirely urban population, in which
migrants do not maintain the ethnic characteristics of their
population of origin.
The results of this systematic investigation of genes,
environmental factors, and their interactions in explaining
the variance of lipoprotein levels indicate that 1) BMI,
smoking, and alcohol intake are strong predictors of blood
lipid levels; and 2) their effects are only marginally modified
by genetic background. These findings have tremendous
clinical and public health implications. They imply that the
documented trends of the growing prevalence of hypercho-
lesterolemia in the population of origin of the study sample
(34) are attributable to modifiable lifestyle behaviors
affecting the population as a whole and that they are not
driven mainly by genetic subgroups. Confirmation of these
results by further studies in other parts of the world would
provide evidence that, at least at present, prevention
strategies should target every individual patient, or the
whole population—that is, not specific genetic subgroups.
These strategies should focus on reducing obesity, in
particular through physical activity (36), elimination of
cigarette smoking, and moderation of alcohol intake.
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APPENDIX
Analytical Strategy for Investigating G 3 G, E 3 E,
and G 3 E Interactions
G3 G, E3 E, and G3 E interaction effects on log(HDL
cholesterol/LDLcholesterol ratio),HDLcholesterol, andLDL
cholesterol were investigated with a systematic analytical
strategy based on stepdown selections of interaction terms
augmenting the variables previously identified as statistically
significant determinants of blood lipid concentrations among
subjects with jointly extreme HDL cholesterol and LDL
cholesterol phenotypes (23). For convenience, age was
recoded as <50 years versus 50 years in these analyses.
First, each of the three types of interaction effects was
analyzed separately. The following sections describe these
effects.
G 3 G interactions
The nine SNPs were first divided into two subgroups, G2
and G7. G2 comprised the HL3b. 2 279 and SR-BI A350A
SNPs that showed significant two-way interactions with
gender (23); G7 comprised the remaining seven SNPs.
Step 1: For each SNP, the previously identified variables
were augmented with all possible three-way G7 3 G7 3
gender and G7 3 G2 3 gender interactions 1 any two-way
G7 3 gender and G7 3 G2 interactions required for a
hierarchical model 1 all possible remaining two-way G7 3
G2, G73 G7, and G23 G2 interactions.
Step 2: p 5 0.10 stepdown selection was applied only to
the step 1 model three-way interactions.
Step 3: p 5 0.10 stepdown selection was applied only to
the step 2 model two-way interactions.
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Step 4: Interactions retained in all step 3 models were
fitted in an overall model.
Step 5: p 5 0.10 stepdown selection was applied only to
the step 4 model interactions.
E 3 E interactions
Step 1: The previously identified variables were aug-
mented with all possible two-way E 3 E interactions.
Step 2: p 5 0.10 stepdown selection was applied only to
the step 1 model interactions.
G 3 E interactions
Step 1: For each of the four E factors of age, BMI,
smoking, and alcohol intake separately, the previously
identified variables were augmented with all nine possible
two-way G 3 E interaction terms (gender and the two
corresponding three-way G2 3 E 3 gender interactions
were automatically included).
Step 2: p 5 0.10 stepdown selection was applied only to
the interactions for each step 1 model.
Step 3: Interactions retained in all step 1 models were
fitted in an overall model.
Step 4: p 5 0.10 stepdown selection was applied only to
the step 3 model interactions.
Finally, the simultaneous effects of the G 3 G, E 3 E,
and G 3 E interactions were assessed by augmenting the
previously identified variables with all of the interaction
terms retained as described above pooled together and
applying p 5 0.05 stepdown selection to only those inter-
actions.
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